1. Report Introduction 2. Opioid-Induced Constipation 2.1. Opioid-Induced Constipation Symptoms 2.2. Opioid-Induced Constipation Causes 2.3. Opioid-Induced Constipation Types 2.4. Opioid-Induced Constipation Risk Factors / Complications 2.5. Opioid-Induced Constipation Pathophysiology 2.6. Opioid-Induced Constipation Diagnosis 2.7. Opioid-Induced Constipation Treatment 3. Comparative Analysis of Marketed and Emerging Products 3.1. Marketed Products 3.1.1. Drug A: Company 3.1.1.1. Product Description 3.1.1.2. Regulatory Milestones 3.1.1.3. Product Development Activities 3.1.1.3.1. General Description Table 3.1.1.4. Global Sales 3.1.1.5. Global API Manufacturers for Drug A 3.1.1.5.1. United States 3.1.1.5.2. Europe 3.1.1.5.3. China 3.1.1.5.4. India 3.1.2. Drug B: Company 3.1.2.1. Product Description 3.1.2.2. Regulatory Milestones 3.1.2.3. Product Development Activities 3.1.2.3.1. General Description Table 3.1.2.4. Global Sales 3.1.2.5. Global API Manufacturers for Drug B 3.1.2.5.1. United States 3.1.2.5.2. Europe 3.1.2.5.3. China 3.1.2.5.4. India Complete details in the report 3.1.3. Emerging Therapies - Late Phase 3.1.3.1. List of Phase III drugs for Opioid-Induced Constipation 4. Appendix 5. Report Methodology 5.1. Secondary Research 5.2. Expert Panel Validation

Table 1 : List of Marketed and Emerging Products Table 2 : Drug A Annual Global Sales from 2012-2023 (in USD million) Table 3 : API Manufacturers for Drug A Region wise Table 4 : API Manufacturers for Drug A for the United States Table 5 : API Manufacturers for Drug A for Europe Table 6 :/ API Manufacturers for Drug A for India Table 7 : API Manufacturers for Drug A for China Table 8 : Drug B Annual Global Sales from 2012-2023 (in USD million) Table 9 : API Manufacturers for Drug B Region wise Table 10 : API Manufacturers for Drug B for the United States Table 11 : API Manufacturers for Drug B for Europe Table 12 : API Manufacturers for Drug B for India Table 13 : API Manufacturers for Drug B for China Table 14 : Drug C Annual Global Sales from 2014-2023 (in USD million) Table 15 : API Manufacturers for Drug C Region wise Table 16 : API Manufacturers for Drug C for the United States Table 17 : API Manufacturers for Drug C for Europe Table 18 : API Manufacturers for Drug C for India Table 19 : API Manufacturers for Drug C for China Table 20 : Drug D, Annual Global Sales from 2013-2023 (in USD million) Table 21 : API Manufacturers for Drug D Region wise Table 22 : API Manufacturers for Drug D for the United States Table 23 : API Manufacturers for Drug D for Europe Table 24 : API Manufacturers for Drug D for India Table 25 : API Manufacturers for Drug D for China Table 26 : Drug E Annual Global Sales from 2014-2023 (in USD million) Table 27 : API Manufacturers for Drug E Region wise Table 28 : API Manufacturers for Drug E for the United States Table 29 : API Manufacturers for Drug E for Europe Table 30 : API Manufacturers for Drug E for India Table 31 : API Manufacturers for Drug E for China Table 32 : List of Phase III drugs for Opioid-Induced ConstipationFigure 1 : Comparative Analysis of Marketed and Emerging Products Figure 2 : Drug A, Annual Global Sales from 2012-2023 (in USD million) Figure 3 : API Manufacturers for Drug A Region wise Figure 4 : Drug B, Annual Global Sales from 2012-2023 (in USD million) Figure 5 : API Manufacturers for Drug B Region wise Figure 6 : Drug C, Annual Global Sales from 2014-2023 (in USD million) Figure 7 : API Manufacturers for Drug C Region wise Figure 8 : Drug D, Annual Global Sales from 2011-2023 (in USD million) Figure 9 : API Manufacturers for Drug D Region wise Figure 10 : Drug E, Annual Global Sales from 2014-2023 (in USD million) Figure 11 : API Manufacturers for Drug E Region wise